Related Experiment Video
Updated: Aug 12, 2026

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
Published on: September 22, 2011
Stress-induced hemodynamic and hemostatic changes in patients with systemic hypertension: effect of verapamil
O C Gebara1, A H Jimenez, C McKenna
1Institute for Prevention of Cardiovascular Disease, Deaconess Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Insights
Sustained-release verapamil reduced harmful stress responses in hypertensive patients. The medication blunted increases in blood pressure and platelet activity, potentially lowering cardiovascular event risk.
Area of Science:
- Cardiovascular Science
- Pharmacology
- Hypertension Research
Background:
- Stress can trigger acute cardiovascular events like myocardial infarction through hemodynamic and hemostatic changes.
- Atherosclerotic plaque disruption and thrombosis are critical in stress-induced cardiac events.
Purpose of the Study:
- To evaluate hemodynamic and hemostatic responses to three stressors (posture, mental stress, cold pressor test).
- To determine if sustained-release verapamil modifies these stress responses in hypertensive patients.
Main Methods:
- A randomized, double-blind, placebo-controlled crossover trial involving 13 mild-to-moderate hypertension patients.
- Patients were assessed after 4 weeks of verapamil or placebo, undergoing postural changes, mental stress, and cold pressor tests.
- Hemodynamic (blood pressure, heart rate) and hemostatic (platelet aggregability) parameters were measured.
Main Results:
- Stress increased systolic pressure, heart rate, and platelet aggregability during placebo.
- Verapamil lowered baseline and post-stress blood pressure but did not change the absolute stress-induced increase.
- Verapamil prevented stress-induced increases in platelet reactivity and reduced responses to epinephrine and collagen.
Conclusions:
- Once-daily sustained-release verapamil blunted potentially harmful stress-induced hemodynamic and hemostatic changes in hypertensive patients.
- Verapamil's effects on platelet reactivity suggest a mechanism for reducing cardiovascular event risk.
- Further research is needed to confirm if these blunted responses translate to a lower incidence of acute cardiovascular events.
Abstract:
Stress-induced hemodynamic and hemostatic responses may acutely trigger atherosclerotic plaque disruption and thrombosis leading to myocardial infarction. This study was designed to evaluate the responses to three stressors and to determine if once-daily sustained release verapamil (Verelan) modified these responses. We studied 13 patients with mild to moderate hypertension in a randomized, double-blind, placebo-controlled crossover trial. After 4 weeks of therapy, patients were evaluated following assumption of the upright posture, mental stress, and cold pressor test. During placebo, the stressors produced an increase in systolic pressure (144 +/- 2 to 167 +/- 3 mmHg, p < 0.001), heart rate (70 +/- 2 to 77 +/- 2 beats/ min, p < 0.001), and platelet aggregability to adenosine diphosphate (threshold concentration fell from 2.8 +/- 0.4 to 1.9 +/- 0.1 microM, p = 0.05) and epinephrine (3.4 +/- 0.9 to 1.6 +/- 0.6 microM, p < 0.001). Verapamil lowered systolic pressure at baseline (144 +/- 2 to 134 +/- 2 mmHg, p < 0.001), and after stress (167 +/- 3 to 154 +/- 3 mmHg, p < 0.001), but did not alter the absolute increase with stress. During verapamil, platelet reactivity did not increase with stress, and the post-stress response to epinephrine was reduced (higher threshold concentration) compared with placebo (3.9 +/- 1.3 vs. 1.5 +/- 0.3 microM, p = 0.05). Verapamil also reduced the response to collagen (increased lag time) at baseline and after stress (111 +/- 9 vs. 91 +/- 3 s, p < 0.01). We conclude that verapamil blunted potentially harmful stress-induced hemodynamic and hemostatic changes. Further studies are required to determine whether these effects translate into a lower incidence of acute cardiovascular events.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Vasodilators
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Hypertension II: Pathophysiology

